13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001915395
Total reported value
$445.7M
$445.7M
10 檔
40.3%
During the Q3 2025 filing period, Tyro Capital Management LLC (CIK: 0001915395) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $445.7M across 10 reported positions.
Tyro Capital Management LLC executed strategic sector rebalancing during Q3 2025, establishing 2 new positions while fully exiting 6 holdings and trimming 2 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Establishment Labs Holdings In | Stock-Other | 16.41% | -3.15% | +1.01% | |
| 2 | CRH | CRH plc | Stock-Materials | 16.06% | +2.90% | +6.79% | |
| 3 | CCOI | Cogent Communications Holdin | Stock-Other | 13.32% | -3.27% | EXIT | |
| 4 | CRS | Carpenter Technology | Stock-Industrials | 11.52% | +3.24% | +62.54% | |
| 5 | GRPN | Groupon Inc | Stock-Other | 9.46% | — | +6.79% | |
| 6 | CROX | Crocs Inc | Stock-Consumer Disc | 9.00% | +4.16% | +60.21% | |
| 7 | SN | SharkNinja, Inc. | Stock-Consumer Disc | 8.91% | +3.89% | +6.79% | |
| 8 | ROAD | Construction Partners Inc-a | Stock-Industrials | 7.76% | +2.81% | +6.79% | |
| 9 | HNGE | Hinge Health Inc-a | Stock-Other | 5.82% | +7.31% | — | |
| 10 | LENZ | Lenz Therapeutics Inc | Stock-Other | 1.74% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SN | SharkNinja, Inc. | +5.5% | +6.79% | Add |
| 2 | CRH | CRH plc | +5% | +6.79% | Add |
| 3 | GRPN | Groupon Inc | +3.4% | +6.79% | Add |
| 4 | CCOI | Cogent Communications Holdin | +2.1% | +46.85% | Add |
| 5 | CROX | Crocs Inc | +1.9% | +60.21% | Add |
| 6 | ROAD | Construction Partners Inc-a | +0.8% | +6.79% | Trim |
| 7 | ✓ | Establishment Labs Holdings In | +0.2% | +1.01% | Add |
| 8 | CRS | Carpenter Technology | -2.6% | +62.54% | Trim |
| 9 | ROIV | Roivant Sciences Ltd. | — | EXIT | Sold out |
| 10 | GE | General Electric | — | EXIT | Sold out |
| 11 | HNGE | Hinge Health Inc-a | — | NEW | New buy |
| 12 | GPGI | Gpgi Inc | — | EXIT | Sold out |
| 13 | LENZ | Lenz Therapeutics Inc | — | NEW | New buy |
| 14 | IMVT | Immunovant Inc | — | EXIT | Sold out |
| 15 | CELH | Celsius Holdings Inc | — | EXIT | Sold out |
| 16 | RHLD | Resolute Holdings Manag | — | EXIT | Sold out |
According to official SEC Form 13F filings, Tyro Capital Management LLC reported a total U.S. public equity portfolio value of $445.7M across 10 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ESTABLISHMENT LABS HOLDINGS IN, CRH, CCOI) accounted for 40.3% of total reported equity market value during Q3 2025.
Top New Position Initiated
HNGE
市值: $15.7M
Top Position Liquidated / Trimmed
ROIV
前期市值: $24.9M
During Q3 2025, Tyro Capital Management LLC's top holdings by market value included ESTABLISHMENT LABS HOLDINGS IN (16.4%)、CRH (16.1%)、CCOI (13.3%). The largest single position, ESTABLISHMENT LABS HOLDINGS IN, represented 16.4% of total portfolio value.
In Q3 2025, Tyro Capital Management LLC made 16 total portfolio adjustments, initiating 2 new buys, adding to 6 positions, trimming 2 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.